Missed opportunities to prevent cardiovascular disease in women with prior preeclampsia.
Adolescent
Adult
Cardiovascular Diseases
/ epidemiology
Clinical Competence
/ statistics & numerical data
Educational Measurement
Female
Health Knowledge, Attitudes, Practice
Humans
Hypertension
/ complications
Internal Medicine
/ education
Medical History Taking
Middle Aged
Obstetrics
/ statistics & numerical data
Pre-Eclampsia
/ epidemiology
Pregnancy
Pregnancy Complications, Cardiovascular
/ epidemiology
Primary Prevention
Retrospective Studies
Risk Factors
Young Adult
Cardiovascular disease
Hypertensive disease of pregnancy
Preeclampsia
Primary prevention
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
06
04
2020
accepted:
14
09
2020
entrez:
1
10
2020
pubmed:
2
10
2020
medline:
12
2
2021
Statut:
epublish
Résumé
Cardiovascular disease (CVD) is the leading cause of death in women in every major developed country and in most emerging nations. Complications of pregnancy, including preeclampsia, indicate a subsequent increase in cardiovascular risk. There may be a primary care provider knowledge gap regarding preeclampsia as a risk factor for CVD. The objective of our study is to determine how often internists at an academic institution inquire about a history of preeclampsia, as compared to a history of smoking, hypertension and diabetes, when assessing CVD risk factors at well-woman visits. Additional aims were (1) to educate internal medicine primary care providers on the significance of preeclampsia as a risk factor for CVD disease and (2) to assess the impact of education interventions on obstetric history documentation and screening for CVD in women with prior preeclampsia. A retrospective chart review was performed to identify women ages 18-48 with at least one prior obstetric delivery. We evaluated the frequency of documentation of preeclampsia compared to traditional risk factors for CVD (smoking, diabetes, and chronic hypertension) by reviewing the well-woman visit notes, past medical history, obstetric history, and the problem list in the electronic medical record. For intervention, educational teaching sessions (presentation with Q&A session) and education slide presentations were given to internal medicine physicians at clinic sites. Changes in documentation were evaluated post-intervention. When assessment of relevant pregnancy history was obtained, 23.6% of women were asked about a history preeclampsia while 98.9% were asked about diabetes or smoking and 100% were asked about chronic hypertension (p < 0.001). Education interventions did not significantly change rates of screening documentation (p = 0.36). Our study adds to the growing body of literature that women with a history of preeclampsia might not be identified as having increased CVD risk in the outpatient primary care setting. Novel educational programming may be required to increase provider documentation of preeclampsia history in screening.
Sections du résumé
BACKGROUND
Cardiovascular disease (CVD) is the leading cause of death in women in every major developed country and in most emerging nations. Complications of pregnancy, including preeclampsia, indicate a subsequent increase in cardiovascular risk. There may be a primary care provider knowledge gap regarding preeclampsia as a risk factor for CVD. The objective of our study is to determine how often internists at an academic institution inquire about a history of preeclampsia, as compared to a history of smoking, hypertension and diabetes, when assessing CVD risk factors at well-woman visits. Additional aims were (1) to educate internal medicine primary care providers on the significance of preeclampsia as a risk factor for CVD disease and (2) to assess the impact of education interventions on obstetric history documentation and screening for CVD in women with prior preeclampsia.
METHODS
A retrospective chart review was performed to identify women ages 18-48 with at least one prior obstetric delivery. We evaluated the frequency of documentation of preeclampsia compared to traditional risk factors for CVD (smoking, diabetes, and chronic hypertension) by reviewing the well-woman visit notes, past medical history, obstetric history, and the problem list in the electronic medical record. For intervention, educational teaching sessions (presentation with Q&A session) and education slide presentations were given to internal medicine physicians at clinic sites. Changes in documentation were evaluated post-intervention.
RESULTS
When assessment of relevant pregnancy history was obtained, 23.6% of women were asked about a history preeclampsia while 98.9% were asked about diabetes or smoking and 100% were asked about chronic hypertension (p < 0.001). Education interventions did not significantly change rates of screening documentation (p = 0.36).
CONCLUSION
Our study adds to the growing body of literature that women with a history of preeclampsia might not be identified as having increased CVD risk in the outpatient primary care setting. Novel educational programming may be required to increase provider documentation of preeclampsia history in screening.
Identifiants
pubmed: 32998727
doi: 10.1186/s12905-020-01074-7
pii: 10.1186/s12905-020-01074-7
pmc: PMC7528479
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Références
BMJ. 2001 Nov 24;323(7323):1213-7
pubmed: 11719411
JAMA Netw Open. 2019 Oct 2;2(10):e1913131
pubmed: 31603489
N Engl J Med. 2017 Aug 17;377(7):613-622
pubmed: 28657417
Hypertens Pregnancy. 2012;31(1):50-8
pubmed: 21332326
Atherosclerosis. 2006 Jan;184(1):201-6
pubmed: 15907856
J Obstet Gynaecol Can. 2007 Nov;29(11):906-908
pubmed: 17977494
Circulation. 2018 Jun 12;137(24):e843-e852
pubmed: 29748185
Am J Med Genet A. 2004 Dec 15;131(3):287-98
pubmed: 15546153
Circulation. 2009 Jan 27;119(3):480-6
pubmed: 19171871
Am J Obstet Gynecol. 2014 Nov;211(5):516.e1-516.e11
pubmed: 24769012
Reprod Toxicol. 2008 Oct;26(2):175-7
pubmed: 18640262
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
BMJ. 2007 Nov 10;335(7627):974
pubmed: 17975258
Obstet Gynecol. 2013 Nov;122(5):1122-31
pubmed: 24150027
Am J Med Genet A. 2008 Oct 15;146A(20):2701-5
pubmed: 18792975
Circulation. 2019 Jun 18;139(25):e1046-e1081
pubmed: 30565953
J Obstet Gynaecol Can. 2015 Apr;37(4):330-337
pubmed: 26001686
Womens Health Issues. 2010 Sep;20(5):304-7
pubmed: 20800765
Nutrients. 2020 Jan 07;12(1):
pubmed: 31936138
Br J Clin Pharmacol. 2007 Oct;64(4):496-509
pubmed: 17506782
J Am Coll Cardiol. 2011 Mar 22;57(12):1404-23
pubmed: 21388771
Hypertens Pregnancy. 2011;30(1):83-92
pubmed: 20818968
Hypertension. 2010 Jul;56(1):166-71
pubmed: 20516394
Fam Pract. 2014 Jun;31(3):247-66
pubmed: 24367069
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Health Care Women Int. 2008 Jan;29(1):3-22
pubmed: 18176877
Hypertension. 2007 Apr;49(4):813-7
pubmed: 17283250
Am J Obstet Gynecol. 2016 Apr;214(4):519.e1-519.e8
pubmed: 26874301
J Obstet Gynaecol Can. 2007 Sep;29(9):705-10
pubmed: 17825134
Biomed Res Int. 2019 Jul 1;2019:2957429
pubmed: 31355253
Circulation. 2018 Feb 20;137(8):877-879
pubmed: 29459475
J Clin Invest. 2016 Aug 1;126(8):2792-4
pubmed: 27454294